Quantitative determination of paclitaxel in human plasma using semi-automated liquid-liquid extraction in conjunction with liquid chromatography/tandem mass spectrometry

被引:42
作者
Basileo, G [1 ]
Breda, M [1 ]
Fonte, G [1 ]
Pisano, R [1 ]
James, CA [1 ]
机构
[1] Pharmacia SPA, Global Drug Metab, I-20014 Milan, Italy
关键词
paclitaxel; semi-automated liquid-liquid extraction; LC-MS; human plasma;
D O I
10.1016/S0731-7085(03)00166-3
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
This paper describes a high-throughput sample preparation procedure combined with LC-MS/MS analysis to measure paclitaxel in human plasma. Paclitaxel and an internal standard were extracted from plasma by a semi-automated robotic method using liquid-liquid extraction. Thereafter compounds were separated on a RP C18 column. Detection was by a PE Sciex API 3000 mass spectrometer equipped with a TurbolonSpray(TM) interface. The compounds were detected in positive ion mode using the mass transition m/z 854.6-->286.2 and m/z 831.6-->263.2 for paclitaxel and the internal standard, respectively. The limit of quantitation for paclitaxel was 1 ng/ml with an imprecision of 5.2% following extraction of 0.1 ml of plasma. Linearity was confirmed over the whole calibration range (1-1000 ng/ml) with correlation coefficients higher than 0.99 indicating good fits of the regression models. The inter and intra-day precision was better than 9.5% and the accuracy ranged from 90.3 to 104.4%. The assay was simple, fast, specific and exhibited excellent ruggedness. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:591 / 600
页数:10
相关论文
共 34 条
  • [1] BITCH F, 1993, J CHROMATOGR, V615, P273
  • [2] EXPEDIENT LIQUID-CHROMATOGRAPHIC ASSAY FOR PACLITAXEL IN PLASMA AFTER ITS ADMINISTRATION TO CANCER-PATIENTS
    ELYAZIGI, A
    YUSUF, A
    [J]. THERAPEUTIC DRUG MONITORING, 1995, 17 (05) : 511 - 515
  • [3] GREM JL, 1987, CANCER TREAT REP, V71, P1179
  • [4] AN ENZYME-IMMUNOASSAY FOR THE DETERMINATION OF TAXOL AND TAXANES IN TAXUS SP TISSUES AND HUMAN PLASMA
    GROTHAUS, PG
    RAYBOULD, TJG
    BIGNAMI, GS
    LAZO, CB
    BYRNES, JB
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 158 (01) : 5 - 15
  • [5] Determination of paclitaxel in biological fluids by micellar electrokinetic chromatography
    Hempel, G
    Lehmkuhl, D
    Krumpelmann, S
    Blaschke, G
    Boos, J
    [J]. JOURNAL OF CHROMATOGRAPHY A, 1996, 745 (1-2) : 173 - 179
  • [6] PHASE-II TRIAL OF TAXOL, AN ACTIVE-DRUG IN THE TREATMENT OF METASTATIC BREAST-CANCER
    HOLMES, FA
    WALTERS, RS
    THERIAULT, RL
    FORMAN, AD
    NEWTON, LK
    RABER, MN
    BUZDAR, AU
    FRYE, DK
    HORTOBAGYI, GN
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (24) : 1797 - 1805
  • [7] Quantification of paclitaxel metabolites in human plasma by high-performance liquid chromatography
    Huizing, MT
    Sparreboom, A
    Rosing, H
    vanTellingen, O
    Pinedo, HM
    Beijnen, JH
    [J]. JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 674 (02): : 261 - 268
  • [8] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC PROCEDURES FOR THE QUANTITATIVE-DETERMINATION OF PACLITAXEL (TAXOL) IN HUMAN URINE
    HUIZING, MT
    ROSING, H
    KOOPMAN, F
    KEUNG, ACF
    PINEDO, HM
    BEIJNEN, JH
    [J]. JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 664 (02): : 373 - 382
  • [9] STEADY-STATE PLASMA-CONCENTRATIONS AND EFFECTS OF TAXOL FOR A 250-MG/M(2) DOSE IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH OVARIAN-CANCER
    JAMISDOW, CA
    KLECKER, RW
    SAROSY, G
    REED, E
    COLLINS, JM
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 33 (01) : 48 - 52
  • [10] PACLITAXEL (TAXOL)
    KOHLER, DR
    GOLDSPIEL, BR
    [J]. PHARMACOTHERAPY, 1994, 14 (01): : 3 - 34